Lung Cancer, Nonsmall Cell, Stage I Completed Phase 2 Trials for Nivolumab (DB09035)

Also known as: NSCLC, Stage I / Stage I NSCLC / Stage I Non-Small Cell Lung Cancer / Non-small Cell Lung Cancer Stage I / Lung cancer non-small cell stage I

IndicationStatusPhase
DBCOND0081601 (Lung Cancer, Nonsmall Cell, Stage I)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03366766Nivolumab, Cisplatin, and Pemetrexed Disodium or Gemcitabine Hydrochloride in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer That Can Be Removed by SurgeryTreatment
NCT02823990TG4010 and Nivolumab in Patients With Lung CancerTreatment
NCT04271384Stereotactic Ablative Radiotherapy With Nivolumab for Early-Stage Operable Non-Small Cell Lung CancerTreatment